According to Onconova Therapeutics's latest financial reports the company has โน1.41 Billion in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-12-31 | โน3.20 B | -21.76% |
2021-12-31 | โน4.09 B | 194.6% |
2020-12-31 | โน1.39 B | -14.15% |
2019-12-31 | โน1.62 B | 36.58% |
2018-12-31 | โน1.18 B | 361.82% |
2017-12-31 | โน0.25 B | -82.37% |
2016-12-31 | โน1.45 B | 10.78% |
2015-12-31 | โน1.31 B | -52.37% |
2014-12-31 | โน2.76 B | -55.29% |
2013-12-31 | โน6.17 B | 38.4% |
2012-12-31 | โน4.46 B | 3010.31% |
2011-12-31 | โน0.14 B |